Characterizing the Epidemiology of Cannabidiol (CBD) Use Among US adults

项目总结/摘要 该项目将直接推进NIDA的战略目标，即“增强对真实的的了解， 毒品使用的世界景观。”本项目的培训活动将包括：1.获取 关于大麻产品作为药物的探索方式的基础知识 产品以及如何进行监管。(TG1)2.发展基本技能和知识 需要应用自然语言处理（NLP）方法进行文本分析。(TG 2）; 3。 进一步发展成为独立的物质使用研究人员所需的一般技能， 包括药物使用人群研究的道德行为，手稿，手稿 写作，政策简报和立法者介绍，跨学科研究（TG 3）。的 本K 01的研究旨在描述美国成年人（18岁以上）使用CBD的流行病学特征。一 本研究将采用单次问卷调查（目标人数n=1500），完成以下具体研究目的：1. 描述CBD用户的特点（目标1），2。将CBD用作替代品或 辅助其他药物。(Aim 2）和3.描述自我报告的CBD相关不良反应 事件（目标3）。这项研究的各个方面及其未来的应用将得到加强， 我对大麻监管（TG 1）和NLP（TG 2）的理解有所增长。传播 项目活动包括同行审查出版物、会议和专题讨论会 演讲，并制定政策简报和国家立法机构的介绍。

Project Summary/Abstract This project will directly advance the NIDA strategic objectives to “enhance knowledge of the real- world landscape of drug use.” The training activities of this project will include: 1. Acquire foundational knowledge of the way that cannabis products have been explored as a medicinal product and how they are regulated. (TG1); 2. Develop the fundamental skills and knowledge required to apply natural language processing (NLP) approaches of text analysis. (TG 2); and 3. Further develop the general skills needed to be an independent substance use researcher, including ethical conduct of research for substance using populations, grantsmanship, manuscript writing, policy briefing and presentation to legislators, and cross-disciplinary research (TG3). The research of this K01 is to characterize epidemiology of CBD use among US adults (18+ years). A single survey (target n=1500) will be used complete the following specific research aims: 1. Describe the characteristics of CBD users (Aim 1), 2. Characterize CBD use as a substitute or adjunct to other medications. (Aim 2), and 3. Characterize self-reported CBD-related adverse events (Aim 3). All aspects of this research and its future applications will be enhanced by the growth in my understanding of cannabis regulation (TG 1) and NLP (TG 2). Dissemination activities for the projects include peer-review publications, conference and symposium presentations, and developing policy briefings and presentations to state legislature.